Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2695 |
|
Actual shortage: | 246 (9%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2440 (91%) | |
Discontinuation Reports |
250 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 247 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
26 (10%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-NITROFURANTOIN | 100MG | CAPSULE | Resolved | 2023-10-05 | 2023-11-30 | 206380 |
TEVA-NITROFURANTOIN | 50MG | CAPSULE | Resolved | 2023-10-19 | 2023-11-30 | 207515 |
TEVA-NITROFURANTOIN | 100MG | CAPSULE | Resolved | 2024-02-15 | 2024-05-30 | 219677 |
TEVA-NORFLOXACIN | 400MG | TABLET | Actual shortage | 2017-03-13 | 2017-10-11 | 1143 |
TEVA-NYSTATIN | 100000UNIT | CREAM | Resolved | 2020-01-24 | 2020-07-10 | 104336 |
TEVA-NYSTATIN | 100000UNIT | SUSPENSION | Resolved | 2020-01-30 | 2020-12-03 | 104914 |
TEVA-NYSTATIN | 100000UNIT | SUSPENSION | Resolved | 2020-02-13 | 2020-04-09 | 106018 |
TEVA-NYSTATIN | 100000UNIT | SUSPENSION | Resolved | 2020-04-23 | 2020-11-26 | 113034 |
TEVA-NYSTATIN | 100000UNIT | SUSPENSION | Resolved | 2022-01-20 | 2022-03-24 | 153141 |
TEVA-NYSTATIN | 100000UNIT | SUSPENSION | Resolved | 2022-10-28 | 2022-12-15 | 173052 |
TEVA-NYSTATIN | 100000UNIT | SUSPENSION | Resolved | 2023-06-19 | 2023-07-14 | 195501 |
TEVA-NYSTATIN | 100000UNIT | SUSPENSION | Resolved | 2023-07-27 | 2023-08-04 | 200231 |
TEVA-NYSTATIN | 100000UNIT | SUSPENSION | Resolved | 2023-08-17 | 2023-12-14 | 202239 |
TEVA-NYSTATIN | 100000UNIT | SUSPENSION | Resolved | 2023-11-30 | 2024-01-11 | 211976 |
TEVA-NYSTATIN | 100000UNIT | SUSPENSION | Actual shortage | 2024-02-08 | 2024-04-18 | 218952 |
TEVA-NYSTATIN | 100000UNIT | SUSPENSION | Actual shortage | 2024-02-08 | 2024-03-07 | 218955 |
TEVA-OLANZAPINE | 10MG | TABLET | Resolved | 2020-04-03 | 2020-05-29 | 110755 |
TEVA-OLANZAPINE | 7.5MG | TABLET | Resolved | 2020-04-23 | 2020-05-14 | 113013 |
TEVA-OLANZAPINE | 5MG | TABLET | Resolved | 2020-05-29 | 2020-07-23 | 116162 |
TEVA-OLANZAPINE | 10MG | TABLET | Resolved | 2020-09-11 | 2020-10-22 | 124116 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
RATIO-METFORMIN | 850MG | TABLET | Discontinued | 2020-07-10 | 2020-07-10 | 120012 |
RATIO-NYSTATIN | 100000UNIT | CREAM | Discontinued | 2019-10-25 | 2019-10-26 | 97243 |
RATIO-NYSTATIN | 100000UNIT | CREAM | Discontinued | 2019-10-25 | 2019-10-26 | 97261 |
RATIO-NYSTATIN | 100000UNIT | CREAM | Discontinued | 2020-02-13 | 2020-02-13 | 106148 |
RATIO-SALBUTAMOL | Discontinued | 2020-02-13 | 2020-02-13 | 106151 | ||
RATIO-TAMSULOSIN | 0.4MG | CAPSULE (SUSTAINED-RELEASE) | Discontinued | 2018-10-19 | 2018-10-19 | 64917 |
TEVA-AMITRIPTYLINE | 10MG | TABLET | Discontinued | 2020-09-24 | 2020-09-24 | 124896 |
TEVA-AMITRIPTYLINE | 50MG | TABLET | Discontinued | 2020-10-22 | 2020-10-24 | 126900 |
TEVA-AMITRIPTYLINE | 10MG | TABLET | Discontinued | 2020-10-22 | 2020-10-24 | 126903 |
TEVA-AMITRIPTYLINE | 25MG | TABLET | Discontinued | 2022-01-07 | 2022-01-07 | 152351 |
TEVA-AMITRIPTYLINE | 25MG | TABLET | Discontinued | 2022-01-07 | 2022-01-07 | 152375 |
TEVA-AMITRIPTYLINE | 50MG | TABLET | Discontinued | 2022-01-07 | 2022-01-07 | 152378 |
TEVA-AMLODIPINE | 5MG | TABLET | Discontinued | 2020-07-10 | 2020-07-10 | 120036 |
TEVA-AMLODIPINE | 10MG | TABLET | Discontinued | 2020-07-10 | 2020-07-10 | 120039 |
TEVA-ARIPIPRAZOLE | 15MG | TABLET | Discontinued | 2019-10-25 | 2019-10-26 | 97264 |
TEVA-ARIPIPRAZOLE | 20MG | TABLET | Discontinued | 2019-10-25 | 2019-10-26 | 97267 |
TEVA-ARIPIPRAZOLE | 5MG | TABLET | Discontinued | 2020-01-24 | 2020-01-24 | 104263 |
TEVA-ARIPIPRAZOLE | 5MG | TABLET | Discontinued | 2020-01-24 | 2020-01-24 | 104283 |
TEVA-ARIPIPRAZOLE | 2MG | TABLET | Discontinued | 2020-05-14 | 2020-05-14 | 115085 |
TEVA-ARIPIPRAZOLE | 20MG | TABLET | Discontinued | 2020-06-11 | 2020-06-11 | 117532 |